Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment

Published:2024-04-08 Issue:7 Volume:9 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Hatae Ryusuke^ORCID,Kyewalabye Keith,Yamamichi Akane,Chen Tiffany,Phyu Su,Chuntova Pavlina,Nejo Takahide^ORCID,Levine Lauren S.,Spitzer Matthew H.^ORCID,Okada Hideho^ORCID

Funder

NIH

Panattoni Family Foundation

Parker Institute for Cancer Immunotherapy

JSPS

Publisher

American Society for Clinical Investigation

Link

https://insight.jci.org/articles/view/177141/files/pdf

Reference44 articles.

1. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

2. Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank

3. Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy

4. Targeting memory T cell metabolism to improve immunity

5. Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives;Cells;2024-04-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP